MediPharm Labs Corp.

Ladies and gentlemen, thank you for standing by and welcome to the MetaFarm Labs third quarter 2021 financial results conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star one on your telephone keypad. Please be advised that today's conference is being recorded. If you require further assistance, please press star zero. I would now like to hand the conference over to your speaker today, Keith Straughan, President of MediPharm Labs. Please go ahead, sir.

Keith Straughan, President, MediPharm Labs Thank you, operator, and good morning. Joining me on the call today are Greg Hunter, our CFO, and Brian Howcroft, our newly appointed CEO. Before we begin, please note the following caution respecting forward-looking statements which is made on behalf of MediPharm Labs and all of its representatives on this call. The statements made on this call will contain forward-looking information that involves risks and uncertainties. Actual results could differ materially from a conclusion, forecast, or projection in the forward-looking information. Certain material factors or assumptions were applied in drawing a conclusion or making a forecast or projection as reflected in the forward-looking information. Additional information about the material factors that could cause actual results to differ materially from the conclusions, forecasts, or projections in the forward-looking information and the material factors or assumptions that were applied in drawing a conclusion or making a forecast or projection as reflected in the forward-looking information are contained in MediPharm Labs filings Canadian and provincial security regulators, which are available on the CDAR website at cdar.com. I'm excited to now hand the call over to Brian Howcroft, our new CEO, for introductory remarks.

Thank you, Keith. Good morning, and thank you for joining our quarterly financial earnings call. My name is Brian Howcroft, and as of today, CEO of Medifarm Labs. I'm joined today by Greg Hunter, Medifarm's chief financial officer, and Keith Strawn, Medifarm's president. Before Greg and Keith present our quarterly results, I would like to say a few words. Firstly, I would like to thank Keith Strawn for his leadership as interim CEO and his support during the CEO transition period. Keith's knowledge of Medifarm, and more broadly, the cannabis industry, is deep, and I greatly look forward to learning from Keith and Medifarm's leadership team as we move forward. Over the coming weeks, I'll be having a lot of dialogue with shareholders, analysts, customers, and the team here at Medifarm as I look to fully understand our position and ways we can more effectively leverage Medifarm's strengths for strategic and operational improvement. I see Medifarm in a similar light in many ways to my experience at South Medic, a business in a highly regulated environment with many strengths. At South Medic, We executed our business strategy and were disciplined about achieving results. In a similar way, I plan to execute against Medifarm's strategy and build a plan to restore the company's profitability through revenue growth and operational improvements. I am well aware that the business has not performed to its full capability over the last 18 months, and I look forward to getting us back on the right path. I will communicate those plans to you as they are developed, and will update you on our progress and successes. I will now turn the call over to Keith to provide a quarterly business update.